4 completed, 1 unknown. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 4, Unknown 1 |
Follow GIP: new trials by email Literature Review of GIP trials Research Report on GIP
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Glucagonotropic Effects of Glucose-dependent Insulinotropic Polypeptide and Alanine in Healthy Individuals Placebo (saline), GIP, Alanine - Effect of iv Administration of GIP and Alanine | Phase 1 | Unknown | University Hospital, Gentofte, Copenhagen | 10 | 2024-01-01 | 2024-05-17 |
| Xenin-25: Novel Regulator of Insulin Secretion and Beta-cell Function Placebo, Glucose-dependent Insulinotropic Polypeptide (GIP), Xenin-25 - Type 2 Diabetes Mellitus | Phase 1 | Completed | Washington University School of Medicine | 38 | 2009-10-01 | 2014-07-22 |
| Study of the Effects of Xenin-25 in Humans With and Without Type 2 Diabetes Mellitus Placebo, Glucose-dependent Insulinotropic Polypeptide (GIP), Xenin-25 - Diabetes | Phase 1 | Completed | Washington University School of Medicine | 40 | 2008-12-01 | 2018-05-03 |
| GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose Glucose-insulinotropic peptide, Glucagon-like peptide-1 - Physiology, Gastroenterology | Phase 1 | Completed | Uppsala University | 15 | 2006-08-01 | 2010-03-03 |
| GIP: Glucose-dependent Insulinotropic Peptide GIP, Modified GIP, Normal Saline - Type 2 Diabetes | Phase 1 | Completed | National Institute on Aging (NIA) | 41 | 2003-02-01 | 2013-11-28 |
Insulin Resistance (3) · Diabetes Mellitus (2) · Diabetes Mellitus, Type 2 (2)
Washington University School of Medicine (2) · National Institute on Aging (NIA) (1) · University Hospital, Gentofte, Copenhagen (1) · Uppsala University (1)
United States (3) · Denmark (1) · Sweden (1)
Burton Wice, PhD (2) · Dominic Reeds, MD (2) · Filip K Knop, MD, PhD (1) · Josephine Egan, MD (1) · Per M Hellstrom, MD, PhD (1)
PMID 22522617, PMID 24183983, PMID 24356886, PMID 24712564
1RC1DK086163-01 (1), R01DK088126 (1)